Abstract
The production of a macrophage migration enhancement factor (MEF) has been achieved as a consequence of administering a desensitizing dose of purified protein derivative (PPD) to Mycobacterium bovis BCG-sensitized rabbits. The migration-enhancing effect was first demonstrated when alveolar macrophages (AM) harvested from desensitized rabbits exhibited marked migration stimulation; whereas maximum migration enhancement was observed 8 days after the administration of PPD, migration enhancement of the AM from these rabbits persisted for up to 12 days. Sera from BCG-sensitized, PPD-desensitized animals exhibited a peak of MEF activity 4 days after desensitization. Maximal MEF activity was demonstrated in culture supernatants of nonadherent spleen cells harvested 8 days after the intravenous desensitizing dose of PPD was given. Control spleen cell culture supernatants did not produce detectable MEF. The route of desensitization with PPD was critical. When PPD was administrated intratracheally, MEF activity was not induced. The intravenous administration of BCG after PPD desensitization reversed migration enhancement to strong migration inhibition. Ammonium sulfate fractionation indicated that two fractions contained MEF activity. MEF activity was retained by dialysis membranes with a 15,000-molecular-weight cutoff but passed through dialysis membranes with a 25,000-molecular-weight cutoff. The mixture of migration inhibition factor with MEF-containing supernatants resulted in the mutual cancellation of both activities. These observations suggest that MEF may be a modulator of macrophage effector responses mediated by migration inhibition factor.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fox R. A., Gregory D. S., Feldman J. D. Macrophage receptors for migration inhibitory factor (MIF), migration stimulatory factor (MSF), and agglutinating factor. J Immunol. 1974 May;112(5):1867–1872. [PubMed] [Google Scholar]
- Fox R. A., Gregory D. S., Feldman J. D. Migration inhibition factor (MIF) and migration stimulation factor (MSF) in fetal calf serum. J Immunol. 1974 May;112(5):1861–1866. [PubMed] [Google Scholar]
- Fox R. A., MacSween J. M., Rajaraman K. Macrophage migration stimulation factor. Scand J Immunol. 1981 Oct;14(4):327–334. doi: 10.1111/j.1365-3083.1981.tb00572.x. [DOI] [PubMed] [Google Scholar]
- Galindo B., Myrvik Q. N. Migratory response of granulomatous alveolar cells from BCG-sensitized rabbits. J Immunol. 1970 Jul;105(1):227–237. [PubMed] [Google Scholar]
- McGee M. P., Myrvik Q. N., Leake E. S. Organization of allergic granulomas and dependence on insoluble antigen. J Reticuloendothel Soc. 1978 Sep;24(3):253–262. [PubMed] [Google Scholar]
- Moore V. L., Myrvik Q. N., Leake E. S. Specificity of a BCG-induced pulmonary granulomatous response in rabbits. Infect Immun. 1973 May;7(5):743–746. doi: 10.1128/iai.7.5.743-746.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Strober S. Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships. Annu Rev Immunol. 1984;2:219–237. doi: 10.1146/annurev.iy.02.040184.001251. [DOI] [PubMed] [Google Scholar]
- Takata I., Gordon M. R., Myrvik Q. N. Demonstration of a macrophage migration enhancement factor in the sera of young rabbits. Cell Immunol. 1985 Oct 1;95(1):137–145. doi: 10.1016/0008-8749(85)90302-8. [DOI] [PubMed] [Google Scholar]
- WALFORD R. L., GALLAGHER R., TROUP G. M. HUMAN LYMPHOCYTE TYPING WITH ISOLOGOUS ANTISERA; TECHNICAL CONSIDERATIONS AND A PRELIMINARY STUDY OF THE CYTOTOXIC REACTION SYSTEM. Transplantation. 1965 May;3:387–401. doi: 10.1097/00007890-196505000-00009. [DOI] [PubMed] [Google Scholar]
- Weisbart R. H., Bluestone R., Goldberg L. S., Pearson C. M. Migration enhancement factor: a new lymphokine. Proc Natl Acad Sci U S A. 1974 Mar;71(3):875–879. doi: 10.1073/pnas.71.3.875. [DOI] [PMC free article] [PubMed] [Google Scholar]